Colombia Pharma Report Under the administration of President Juan Manuel Santos, Colombia is focusing on bolstering the commercial sector. Thanks to the ratification of free trade agreements with 14 countries around the world since 2011, including the United States, foreign direct investment reached a record high of COP 29 trillion (USD 16 billion) in 2012. While this is good news for the pharmaceutical industry, there is still a strong debate about how healthcare in Colombia can be improved. While Colombia enjoys near-universal coverage, a feat rarely seen in Latin America, the financial strain caused by this broad coverage has created the need for change. The industry is watching as the country enters a period of transformation. Written after exclusive interviews with the country’s decision makers from local and multinational companies, manufacturers, distributors, experts, legislators, this is a unique resource for those looking beyond figures. Contributors include: Ministry of Health and Social Protection, Novartis, Cegedim, Genfar, Eurofarma, Johnson & Johnson, Medtronic Focus Reports serves business professionals in the Pharmaceutical industry. The country reports offer a snapshot of the challenges and issues faced by an industry through the voice and insight of the decision makers at governmental, legislative and corporate levels. They are based on exclusive interviews conducted by our staff.